The Russian government plans to significantly reduce public procurements of cancer drugs in 2027, that will be mainly due to ...

US clinical-stage biotech Tortugas Neuroscience has announced positive Phase IIb trial results for obuprazine (TRTL-107), the ...

Telix Pharmaceuticals (ASX: TLX) began US commercial supply of Pixclara (floretyrosine F 18), while Knight Therapeutics (TSX: ...

Italy's Sibylla Biotech, an oncology firm developing small-molecule protein degraders that interfere with protein folding, ...

US biotech companies Bambusa Therapeutics and Aspen Neuroscience have filed for initial public offerings (IPOs), seeking ...

Chai Discovery, the San Francisco-based AI company building computer-aided design tools for molecules, has announced a ...

Canadian eye health company Bausch + Lomb (NYSE: BLCO) has appointed Thomas Appio interim chief executive following an ...

Key analyses from the positive Phase III OBERON and TITANIA trials and results from the PROSPERO long-term extension trial ...

New US cancer indications and an antiviral approval featured among human medicines regulatory updates from October 6 to 12, ...

ANI Pharmaceuticals today announced that both 6-month and 24-month data from SYNCHRONICITY, its Phase IV, open-label, ...

Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the ...

US rare diseases biotech Mirum Pharmaceuticals today announced top-line results from the Phase III EXPAND study evaluating ...